166 related articles for article (PubMed ID: 27918935)
1. Depressive symptoms in Parkinson's disease correlate with cortical atrophy over time.
Hanganu A; Bruneau MA; Degroot C; Bedetti C; Mejia-Constain B; Lafontaine AL; Chouinard S; Monchi O
Brain Cogn; 2017 Feb; 111():127-133. PubMed ID: 27918935
[TBL] [Abstract][Full Text] [Related]
2. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
[TBL] [Abstract][Full Text] [Related]
3. Cortical thickness in de novo patients with Parkinson disease and mild cognitive impairment with consideration of clinical phenotype and motor laterality.
Danti S; Toschi N; Diciotti S; Tessa C; Poletti M; Del Dotto P; Lucetti C
Eur J Neurol; 2015 Dec; 22(12):1564-72. PubMed ID: 26212370
[TBL] [Abstract][Full Text] [Related]
4. Cortical thinning across Parkinson's disease stages and clinical correlates.
Wilson H; Niccolini F; Pellicano C; Politis M
J Neurol Sci; 2019 Mar; 398():31-38. PubMed ID: 30682518
[TBL] [Abstract][Full Text] [Related]
5. Cortical thinning is associated with disease stages and dementia in Parkinson's disease.
Zarei M; Ibarretxe-Bilbao N; Compta Y; Hough M; Junque C; Bargallo N; Tolosa E; Martí MJ
J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):875-81. PubMed ID: 23463873
[TBL] [Abstract][Full Text] [Related]
6. Patterns of cortical thickness and surface area in early Parkinson's disease.
Jubault T; Gagnon JF; Karama S; Ptito A; Lafontaine AL; Evans AC; Monchi O
Neuroimage; 2011 Mar; 55(2):462-7. PubMed ID: 21184830
[TBL] [Abstract][Full Text] [Related]
7. Progression of Parkinson's disease patients' subtypes based on cortical thinning: 4-year follow-up.
Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
Parkinsonism Relat Disord; 2019 Jul; 64():286-292. PubMed ID: 31103485
[TBL] [Abstract][Full Text] [Related]
8. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
[TBL] [Abstract][Full Text] [Related]
9. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
[TBL] [Abstract][Full Text] [Related]
10. Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease.
Ye BS; Jeon S; Yoon S; Kang SW; Baik K; Lee Y; Chung SJ; Oh JS; Moon H; Kim JS; Lee PH; Sohn YH
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):197-204. PubMed ID: 28951497
[TBL] [Abstract][Full Text] [Related]
11. Cortical Thickness, Surface Area and Subcortical Volume Differentially Contribute to Cognitive Heterogeneity in Parkinson's Disease.
Gerrits NJ; van Loenhoud AC; van den Berg SF; Berendse HW; Foncke EM; Klein M; Stoffers D; van der Werf YD; van den Heuvel OA
PLoS One; 2016; 11(2):e0148852. PubMed ID: 26919667
[TBL] [Abstract][Full Text] [Related]
12. Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis.
Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Tolosa E; Junque C
Parkinsonism Relat Disord; 2018 May; 50():3-9. PubMed ID: 29449187
[TBL] [Abstract][Full Text] [Related]
13. Patterns of cortical thinning in nondemented Parkinson's disease patients.
Uribe C; Segura B; Baggio HC; Abos A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
Mov Disord; 2016 May; 31(5):699-708. PubMed ID: 27094093
[TBL] [Abstract][Full Text] [Related]
14. Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration.
Hanganu A; Bedetti C; Jubault T; Gagnon JF; Mejia-Constain B; Degroot C; Lafontaine AL; Chouinard S; Monchi O
Mov Disord; 2013 Sep; 28(10):1360-9. PubMed ID: 23801590
[TBL] [Abstract][Full Text] [Related]
15. Cortical Thinning and Cognitive Impairment in Parkinson's Disease without Dementia.
Zhang L; Wang M; Sterling NW; Lee EY; Eslinger PJ; Wagner D; Du G; Lewis MM; Truong Y; Bowman FD; Huang X
IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(2):570-580. PubMed ID: 29610105
[TBL] [Abstract][Full Text] [Related]
16. Progression of cortical thinning in early Parkinson's disease.
Ibarretxe-Bilbao N; Junque C; Segura B; Baggio HC; Marti MJ; Valldeoriola F; Bargallo N; Tolosa E
Mov Disord; 2012 Dec; 27(14):1746-53. PubMed ID: 23124622
[TBL] [Abstract][Full Text] [Related]
17. Cortical and subcortical brain atrophy in Parkinson's disease with visual hallucination.
Watanabe H; Senda J; Kato S; Ito M; Atsuta N; Hara K; Tsuboi T; Katsuno M; Nakamura T; Hirayama M; Adachi H; Naganawa S; Sobue G
Mov Disord; 2013 Oct; 28(12):1732-6. PubMed ID: 24150865
[TBL] [Abstract][Full Text] [Related]
18. Progression of small vessel disease correlates with cortical thinning in Parkinson's disease.
Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Tan L; Kandiah N
Parkinsonism Relat Disord; 2016 Oct; 31():34-40. PubMed ID: 27397577
[TBL] [Abstract][Full Text] [Related]
19. Regional cortical thickness and cognitive functions in non-demented Parkinson's disease patients: a pilot study.
Pellicano C; Assogna F; Piras F; Caltagirone C; Pontieri FE; Spalletta G
Eur J Neurol; 2012 Jan; 19(1):172-5. PubMed ID: 21771199
[TBL] [Abstract][Full Text] [Related]
20. Cerebral perfusion and cortical thickness indicate cortical involvement in mild Parkinson's disease.
Madhyastha TM; Askren MK; Boord P; Zhang J; Leverenz JB; Grabowski TJ
Mov Disord; 2015 Dec; 30(14):1893-900. PubMed ID: 25759166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
